Verywell Health on MSN2mon
Spravato Nasal Spray Can Now Be Used Alone for Treatment-Resistant DepressionThe Food and Drug Administration (FDA) has expanded its approval of a ketamine nasal spray, Spravato (esketamine), as a ...
Johnson & Johnson has priced its new Spravato nasal spray for treatment-resistant depression ... report on Spravato (esketamine) and says the drug would need to be between 25% and 52% cheaper ...
Hosted on MSN2mon
FDA-Approved Nasal Spray For Depression Is First Of Its KindA ketamine-based nasal spray is officially the first and only ... The FDA first approved the Johnson & Johnson drug, called Spravato (esketamine), for some cases of depression in 2019, but it ...
But you should take doses of the nasal corticosteroid or nasal decongestant at least 1 hour before you receive a dose of Spravato. In studies of Spravato, the nasal decongestant oxymetazoline was ...
The U.S. Food and Drug Administration approved the expanded use of ARS Pharmaceuticals' nasal spray for severe allergic reactions in patients who weigh between 15 and 30 kilograms, the company said on ...
Tesla and SpaceX CEO Elon Musk clarified that he uses only "a small amount once every other week or something like that" ...
The UK agency declined to recommend NHS funding for Spravato (esketamine) nasal spray in 2020 – following ... convinced by the clinical data for the drug and believed it was not cost-effective.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback